Metagenomi, Inc (MGX) - Sotuvning sof marjinal rentabelligi

MGX (Metagenomi) - kompaniyaning tovar belgisi

Sof marja tuzilmasi daromadlilik dinamikasini namoyish etadi, bunda -1329.30 darajasi ushbu ko'rsatkichning joriy qiymatini aks ettiradi. Metagenomi, Inc. (MGX) aniq CRISPR tahrirlashni ishlab chiqishda sezilarli ilmiy salohiyatga ega. Metagenomika orqali tabiiy fermentlarni qidirish kompaniyaga patentlarni chetlab o'tish va xavfsiz terapevtik vositalarni yaratish imkonini beradi. Kirish uchun yuqori texnologik to'siq va himoyalangan intellektual mulk bazasi kompaniyaga barqaror raqobatbardosh ustunlikni ta'minlaydi.

MGX: Metagenomi, Inc. Kompaniya sotuv marjasi 21.02.2024 - 20.11.2026

Metagenomi, Inc. (MGX) kompaniyasi koʻrsatkichlari kesimi va tahlili

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Kompaniyaning jamlanma tahlili:Metagenomi, Inc - MGX
Metagenomi Therapeutics yetakchi tovari

Sof foyda marjasi har bir dollarlik tushumning qancha qismi foyda ekanligini belgilaydi va tijorat samaradorligining asosiy ko'rsatkichi bo'lib xizmat qiladi. Kompaniya savdo marjalarini tahlil qilish xarajatlar tuzilmasidagi o'zgarishlarni choraklik kechikishlarsiz real vaqt rejimida kuzatish imkonini beradi. Ushbu ko'rsatkich sof foydaning umumiy savdoga nisbati sifatida hisoblanadi. Metagenomi, Inc. (MGX) uchun ushbu tendentsiya ilmiy jamoaning klinik platformalar uchun xarajatlarni optimallashtirish qobiliyatini aks ettiradi. Shaffof risk menejmenti investorlarga sog'liqni saqlash gigantlari bilan uzoq muddatli sheriklik davrida biznes modelining barqarorligini baholashga yordam beradi.

Muhim raqobatchilar

TEM: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Repligen Inc. - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi RNA|CRSP - Sof marja|GeneDx - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi RARE|Beam Tx - Sotuvning sof marjinal rentabelligi|SRPT - Sotuvning sof marjinal rentabelligi|TWST (Twist Bio) - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof rentabelligi TXG|Sof foyda bo'yicha sotuv rentabelligi NTLA|Stoke Therapeutics Inc (STOK) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi BLFS|Sof marja WVE (Wave Life Sciences Corp)|Sof marja Maze Therapeutics MAZE|Sof foyda normasi SION|PRME - Sof marja|Kompaniya sotuv marjasi Taysha TSHA|QURE: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi MeiraGTx PLC|RGNX (REGENXBIO Inc) - Sotuvning sof marjinal rentabelligi|solidbio.com (SLDB) - Kompaniya sotuv marjasi|Sof marja Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Sotuvning sof rentabelligi|Benitec Biopharma - Sof foyda bo'yicha sotuv rentabelligi|DSGN: Sotuvning sof rentabelligi|RCKT: Sof foyda bo'yicha sotuv rentabelligi|FDMT - Sotuvning sof marjinal rentabelligi|LXEO: Sotuvning sof marjinal rentabelligi|Korro Bio Inc. - Sof foyda normasi|EDIT (editasmedicine.com) - Sotuvning sof marjinal rentabelligi|Sof marja SLN|Sof marja ProQR Therapeutics NV (PRQR)|Codexis - Sotuvning sof rentabelligi|Sof marja Sangamo SGMO|NAUT: Sotuvning sof rentabelligi|Precision BioSciences Inc. - Sotuvning sof marjinal rentabelligi|GBIO - Sotuvning sof marjinal rentabelligi|BOLD: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi XCUR|Sof marja Imunon|Phio Pharmaceuticals - Sof foyda marjasi|Sof marja Mustang Bio, Inc. (MBIO)|Kompaniya sotuv marjasi TransCode Therapeutics, Inc.|Sof marja Bionano Genomics BNGO|Sof foyda normasi APDN|BLUE - Sof marja|Sof foyda marjasi IPA|Omega Therapeutics, Inc. (OMGA) - Sof marja|Singular Genomics Corp (OMIC) - Sotuvning sof marjinal rentabelligi|RGLS (Regulus Therapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|SYRS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi TBIO (Telesis Bio Inc.)|Sotuvning sof marjinal rentabelligi TRACON Pharmaceuticals Inc. (TCON)|Sof marja Unity Bio UBX